[Other sedatives and hypnotics-related disorders].
Matsumoto
Chima
C
Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Japan.
Nakamura
Jun
J
D000928:Antidepressive Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D053961:Azabicyclo Compounds; D001968:Bromisovalum / Q000009:adverse effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D010879:Piperazines / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D000077334:Zolpidem
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D053961:Azabicyclo Compounds; D006993:Hypnotics and Sedatives; D010879:Piperazines; D011725:Pyridines; C515050:zopiclone; D001968:Bromisovalum; D000077334:Zolpidem